Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
6.75
-0.36 (-5.06%)
Apr 30, 2026, 3:04 PM CST

SHE:002581 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-160.83-137.31-332.46-14.68271
Depreciation & Amortization
38.4941.6770.6374.8665.9
Other Amortization
0.151.094.412.593.55
Loss (Gain) From Sale of Assets
-3.82-1.166.33-0.050.15
Asset Writedown & Restructuring Costs
43.6569.64293.8813.610.48
Loss (Gain) From Sale of Investments
-23.91-44.08-172.68-217.45-471.94
Provision & Write-off of Bad Debts
--4.73-27.56-3.48-2.2
Other Operating Activities
17.9610.0239.0722.8721.01
Change in Accounts Receivable
-230.1867.8169.762.4575.08
Change in Inventory
20.82-9.34-15.16-16.136.53
Change in Accounts Payable
30.5711.356.2468.51-15.39
Change in Other Net Operating Assets
29.28-8.3115.5--
Operating Cash Flow
-253.73-6.55-36.51-54.49-46.02
Capital Expenditures
-179.7-9.01-4.32-31.46-60.85
Sale of Property, Plant & Equipment
4.078.174.7724.450.02
Divestitures
-73.75---
Investment in Securities
--0.03-285
Other Investing Activities
143.02294.16256.17-3.4-
Investing Cash Flow
-32.61367.06256.65-38.42-55.83
Short-Term Debt Issued
---227.5218
Long-Term Debt Issued
82.7713.8462.95-
Total Debt Issued
82.7713.84290.45218
Short-Term Debt Repaid
----229-188
Long-Term Debt Repaid
-19.78-10.56-214.7-13.39-25.3
Total Debt Repaid
-19.78-10.56-214.7-242.39-213.3
Net Debt Issued (Repaid)
-11.78-7.79-200.8748.064.7
Common Dividends Paid
-1.14-0.18-10.28-8.04-6.71
Other Financing Activities
-1.12--7.887.49
Financing Cash Flow
-14.03-7.97-211.1447.895.49
Foreign Exchange Rate Adjustments
-00-00-0
Net Cash Flow
-300.37352.549-45-96.35
Free Cash Flow
-433.43-15.56-40.82-85.95-106.86
Free Cash Flow Margin
-157.72%-4.32%-9.50%-24.07%-26.53%
Free Cash Flow Per Share
-0.66-0.02-0.06-0.13-0.16
Cash Income Tax Paid
15.6322.631.7515.4920.31
Levered Free Cash Flow
-337.5532.36-107.8485.691.83
Unlevered Free Cash Flow
-337.5532.49-102.1891.576.13
Change in Working Capital
-165.4258.3281.8867.2666.03
Source: S&P Global Market Intelligence. Standard template. Financial Sources.